TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy
Key Statistics
- 3-fold — Rise in maternal cortisol in pregnancy
- 5–10× — ↑ Gestational diabetes risk, chronic steroids
- OR 3.35 — Oral clefts, 1st-trimester exposure
Don't-miss facts
-
Chronic maternal corticosteroid use does NOT replace a standard fluorinated ACS course if preterm delivery threatens at 24–34 weeks
-
ACS regimens: betamethasone 12 mg IM ×2 (24h apart) or dexamethasone 6 mg IM ×4 (12h apart); RCOG accepts any regimen totalling 24 mg in 24–48h
-
Dexamethasone/betamethasone cross placenta readily (poor 11β-HSD2 substrates, only 1.8%/7.1% inactivated) vs cortisol (67% inactivated) and prednisolone (51% inactivated)
-
ACS ↓RDS: RR 0.66 (95% CI 0.59–0.73) from 21 studies/4269 infants; serial (>2) courses not recommended
-
1st-trimester corticosteroid exposure: possible ↑oral clefts (OR 3.35) – but large Danish registry found no increased risk; evidence conflicting
-
Chronic corticosteroid use → 5–10-fold ↑gestational diabetes risk – offer GTT
-
Avoid betamethasone in breastfeeding; prefer prednisolone, avoid feed for 4h post-dose
-
Mifepristone + long-term corticosteroids (e.g. post-transplant) is contraindicated
Placental transfer at a glance
Cross readily: dexamethasone, betamethasone (fluorinated) More placenta-metabolised: cortisol, prednisolone
Abbreviation Key
- HPA — hypothalamic–pituitary–adrenal (axis)
- OR — odds ratio
- CRH — corticotrophin-releasing hormone
- CI — confidence interval
- ACTH — adrenocorticotrophin hormone
- RCOG — Royal College of Obstetricians and Gynaecologists
- 11β-HSD2 — 11β-hydroxysteroid dehydrogenase type 2
- ACOG — American College of Obstetricians and Gynecologists
- RDS — respiratory distress syndrome
- GTT — glucose tolerance test
- ACS — antenatal corticosteroids
- NICU — neonatal intensive care unit
- RR — risk ratio
Source: AlSaad D et al. Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy. The Obstetrician & Gynaecologist 2019;21:117–125. doi:10.1111/tog.12556
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).